Akari Therapeutics PLC (AKTX)
1.36
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
DBV Technologies SA | -0.808M |
Cellectis SA | -15.51M |
Adaptimmune Therapeutics PLC | 176.54M |
Biodexa Pharmaceuticals Plc | -0.3289M |
NuCana PLC | 3.594M |